I. J. Fidler

8.4k total citations · 1 hit paper
105 papers, 7.0k citations indexed

About

I. J. Fidler is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I. J. Fidler has authored 105 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 33 papers in Oncology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I. J. Fidler's work include Cancer Research and Treatments (24 papers), Cancer Cells and Metastasis (18 papers) and Immunotherapy and Immune Responses (13 papers). I. J. Fidler is often cited by papers focused on Cancer Research and Treatments (24 papers), Cancer Cells and Metastasis (18 papers) and Immunotherapy and Immune Responses (13 papers). I. J. Fidler collaborates with scholars based in United States, Australia and Japan. I. J. Fidler's co-authors include C Bucana, C D Bucana, Janet E. Price, Robert Radinsky, William E. Fogler, A. J. Schroit, Zhongyun Dong, R. S. Brodey, Mordechai Gutman and Zhitao Dong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

I. J. Fidler

105 papers receiving 6.7k citations

Hit Papers

Critical factors in the biology of human cancer metastasi... 1990 2026 2002 2014 1990 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. J. Fidler United States 43 3.1k 2.6k 1.6k 1.5k 1.2k 105 7.0k
Janet E. Price United States 48 3.7k 1.2× 3.2k 1.2× 1.0k 0.6× 1.5k 1.0× 1.0k 0.9× 136 7.5k
C D Bucana United States 40 2.7k 0.8× 2.0k 0.8× 1.3k 0.8× 1.2k 0.8× 874 0.7× 81 5.7k
Philip E. Thorpe United States 51 5.8k 1.8× 2.6k 1.0× 3.5k 2.1× 2.4k 1.6× 683 0.6× 134 10.6k
Philip S. Rudland United Kingdom 59 7.2k 2.3× 2.6k 1.0× 1.2k 0.7× 2.2k 1.5× 914 0.8× 251 10.3k
Anthony P. Albino United States 48 3.4k 1.1× 2.5k 1.0× 1.3k 0.8× 1.2k 0.8× 777 0.7× 115 6.6k
Raffaella Giavazzi Italy 57 6.2k 2.0× 4.0k 1.5× 1.4k 0.9× 3.4k 2.3× 944 0.8× 232 11.4k
Janet Plescia United States 38 6.1k 2.0× 2.4k 0.9× 1.5k 0.9× 1.6k 1.1× 775 0.7× 52 8.8k
Michael G. Brattain United States 56 6.8k 2.2× 4.1k 1.6× 742 0.4× 1.7k 1.2× 912 0.8× 219 10.3k
Giulia Taraboletti Italy 47 4.0k 1.3× 2.1k 0.8× 989 0.6× 2.2k 1.5× 506 0.4× 112 7.1k
Gunhild M. Mælandsmo Norway 49 5.1k 1.6× 3.3k 1.2× 1.4k 0.9× 2.4k 1.6× 1.3k 1.1× 219 8.7k

Countries citing papers authored by I. J. Fidler

Since Specialization
Citations

This map shows the geographic impact of I. J. Fidler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. J. Fidler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. J. Fidler more than expected).

Fields of papers citing papers by I. J. Fidler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. J. Fidler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. J. Fidler. The network helps show where I. J. Fidler may publish in the future.

Co-authorship network of co-authors of I. J. Fidler

This figure shows the co-authorship network connecting the top 25 collaborators of I. J. Fidler. A scholar is included among the top collaborators of I. J. Fidler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. J. Fidler. I. J. Fidler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kitadai, Yasuhiko, Ken Haruma, Kazuhito Naka, et al.. (1999). Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. British Journal of Cancer. 81(4). 647–653. 131 indexed citations
3.
Watanabe, M., et al.. (1997). Orthotopic implantation of stomach cancer. 11(9). 1011–1015. 1 indexed citations
4.
Dong, Zhitao, et al.. (1995). Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362.. PubMed. 55(14). 3123–31. 70 indexed citations
6.
Gutman, Mordechai, Rakesh K. Singh, Janet E. Price, D. Fan, & I. J. Fidler. (1994). Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration.. PubMed. 14(1-6). 362–71. 26 indexed citations
7.
Dong, Zhongyun, Xiaoxia Qi, Keping Xie, & I. J. Fidler. (1993). Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages.. The Journal of Immunology. 151(5). 2717–2724. 142 indexed citations
8.
Fujimaki, Takamitsu, et al.. (1993). CRITICAL FACTORS REGULATING SITE-SPECIFIC BRAIN METASTASIS OF MURINE MELANOMAS. International Journal of Oncology. 3(5). 789–99. 21 indexed citations
9.
Stephenson, Robert A., Colin P. Dinney, Kazuo Gohji, et al.. (1992). Metastatic Model for Human Prostate Cancer Using Orthotopic Implantation in Nude Mice. JNCI Journal of the National Cancer Institute. 84(12). 951–957. 259 indexed citations
10.
Naito, Sei, Joichi Kumazawa, Andrew C. von Eschenbach, & I. J. Fidler. (1991). Metastatic Heterogeneity of Human Renal Cell Carcinoma. Urologia Internationalis. 47(1). 90–95. 2 indexed citations
11.
Fidler, I. J., et al.. (1989). Activated human blood monocytes trigger the antitumor activity of blood polymorphonuclear cells.. PubMed. 8(4). 427–37. 6 indexed citations
12.
Li, Li, et al.. (1989). Correlation of Growth Capacity of Human Tumor Cells in Hard Agarose With Their In Vivo Proliferative Capacity at Specific Metastatic Sites. JNCI Journal of the National Cancer Institute. 81(18). 1406–1412. 117 indexed citations
13.
Hume, David, Paul Pavli, Robert E. Donahue, & I. J. Fidler. (1988). The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo.. The Journal of Immunology. 141(10). 3405–3409. 157 indexed citations
14.
LeGrue, Stephen J., I Saiki, Cynthia A. Romerdahl, & I. J. Fidler. (1987). Systemic macrophage activation by liposomes containing MTP-PE in mice immunosuppressed with cyclosporine.. PubMed. 43(4). 584–6. 2 indexed citations
15.
Fidler, I. J.. (1983). The generation of tumoricidal activity in macrophages for the treatment of established metastases.. PubMed. 36. 421–35. 5 indexed citations
16.
Schroit, A. J., IR Hart, Jeppe Madsen, & I. J. Fidler. (1983). Selective delivery of drugs encapsulated in liposomes: natural targeting to macrophages involved in various disease states.. PubMed. 2(2). 97–100. 31 indexed citations
17.
Schroit, A. J. & I. J. Fidler. (1982). Delivery of macrophage-augmenting factors encapsulated in liposomes for destruction of tumor metastases.. PubMed. 102 pt A. 347–55. 1 indexed citations
18.
Fidler, I. J. & IR Hart. (1982). The development of biological diversity and metastatic potential in malignant neoplasms.. PubMed. 4(1-2). 161–76. 13 indexed citations
19.
Fidler, I. J., S Sone, William E. Fogler, et al.. (1982). Efficacy of liposomes containing a lipophilic muramyl dipeptide derivative for activating the tumoricidal properties of alveolar macrophages in vivo. 1(1). 43–55. 55 indexed citations
20.
Brodey, R. S., I. J. Fidler, & Steen Bech‐Nielsen. (1975). Correlation of in Vitro Immune Response with Clinical Course of Malignant Neoplasia in Dogs. American Journal of Veterinary Research. 36(1). 75–80. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026